- In April 2022, EMZ Partners acquired a majority stake in FotoFinder Systems GmbH, the leading provider of skin visualization and diagnostic systems. This acquisition aims to further strengthen FotoFinder’s position in the dermatology market by supporting its growth and innovation. The company plans to enhance its offerings in skin imaging technology and expand its reach to more healthcare providers globally. This development is expected to drive advancements in skin cancer detection, providing better diagnostic tools for dermatologists. The acquisition will have a significant impact on the market by increasing the availability of advanced dermatology endoscopy devices and improving early detection capabilities worldwide
Frequently Asked Questions
Companies such as HEINE Optotechnik GmbH & Co. KG (Germany), 3Gen Consulting (U.S.), MetaOptima Technology Inc. (Canada), Optilia Instruments AB (Sweden), AMD Global Telemedicine (U.S.) and among others, are the major companies in the dermatology endoscopy devices market.
In April 2022, EMZ Partners acquired a majority stake in FotoFinder Systems GmbH to strengthen its position in the dermatology market. This acquisition aims to expand FotoFinder’s reach globally and drive advancements in skin cancer detection and diagnostic technology.
The countries covered in the dermatology endoscopy devices market are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Netherlands, Switzerland, Austria, Poland, Norway, Ireland, Hungary, Lithuania, rest of Europe, China, Japan, India, South Korea, Australia, Taiwan, Philippines, Thailand, Malaysia, Vietnam, Indonesia, Singapore, rest of Asia-Pacific, Brazil, Argentina, Chili, Colombia, Peru, Venezuela, Ecuador, Uruguay, Paraguay, Bolivia, Trinidad and Tobago, Curaçao, rest Of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, rest of Middle East and Africa, Guatemala, Costa Rica, Honduras, EL Salvador, Nicaragua, and rest of Central America.
